Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system.
Zipp
F
F
Dept of Neurology, Charité, 10098 Berlin, Germany. frauke.zipp@charite.de
Krammer
P H
PH
Weller
M
M
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology; D001921:Brain / Q000276:immunology / Q000473:pathology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology / Q000473:pathology; D053222:Fas Ligand Protein; D006801:Humans; D008562:Membrane Glycoproteins / Q000502:physiology*; D051379:Mice; D017628:Microglia / Q000276:immunology / Q000473:pathology; D009103:Multiple Sclerosis / Q000276:immunology* / Q000473:pathology; D009836:Oligodendroglia / Q000473:pathology; D051381:Rats; D011917:Rats, Inbred Lew; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D019014:fas Receptor / Q000502:physiology*
C505661:FASLG protein, human; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; C505662:Faslg protein, rat; D008562:Membrane Glycoproteins; D019014:fas Receptor